We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.57B
AUM Growth
+$696M
Cap. Flow
-$177B
Cap. Flow %
-2,344.61%
Top 10 Hldgs %
17.36%
Holding
505
New
149
Increased
83
Reduced
97
Closed
138

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$136M
2
ATVI
Activision Blizzard
ATVI
+$132M
3
CELG
Celgene Corp
CELG
+$86.3M
4
LYFT icon
Lyft
LYFT
+$78.3M
5
GG
Goldcorp Inc
GG
+$75.2M

Top Sells

Rank Stock Value
1
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$96.2M
2
PANW icon
Palo Alto Networks
PANW
+$94.9M
3
FLEX icon
Flex
FLEX
+$77.4M
4
CTSH icon
Cognizant
CTSH
+$73.1M
5
LEN icon
Lennar Class A
LEN
+$70M

Sector Composition

Rank Sector Weight
1 Technology 23.08%
2 Industrials 13.88%
3 Healthcare 11.63%
4 Consumer Discretionary 9.64%
5 Financials 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECPG icon
301
Encore Capital Group
ECPG
$2.13B
$1.42M 0.02%
+52,026
New +$1.55M
OPTU
302
Optimum Communications Inc
OPTU
$301M
$1.4M 0.02%
+65,000
New +$1.31M
DPLO
303
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.34M 0.02%
+229,895
New +$2.37M
KALA icon
304
KALA BIO
KALA
$14.5M
$1.3M 0.02%
63
– –
STKL
305
DELISTED
SunOpta
STKL
$1.27M 0.02%
365,981
-733,019
-67% -$2.84M
DCPH
306
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.24M 0.02%
53,281
-39,719
-43% -$1.04M
HTGM
307
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$1.22M 0.02%
2,719
+8
+0.3% +$3.5K
TECH icon
308
Bio-Techne
TECH
$11.3B
$1.21M 0.02%
+24,436
New +$1.1M
WAT icon
309
Waters Corp
WAT
$39.9B
$1.11M 0.01%
4,409
-226,634
-98% -$51.6M
TGLS icon
310
Tecnoglass Holdings Inc.
TGLS
$1.96B
$1.09M 0.01%
+150,000
New +$1.23M
THG icon
311
Hanover Insurance
THG
$7.98B
$1.08M 0.01%
+9,494
New +$1.09M
C icon
312
Citigroup
C
$226B
$1.07M 0.01%
+17,202
New +$1.07M
PCAR icon
313
PACCAR
PCAR
$70.1B
$1.07M 0.01%
+23,532
New +$1.02M
CHMA
314
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.04M 0.01%
+200,000
New +$881K
ACET icon
315
Adicet Bio
ACET
$74.7M
$1.02M 0.01%
+1,339
New +$1.22M
NIO icon
316
CALL
NIO
NIO
$11.9B
$1.02M 0.01%
+200,000
New +$1.42M
NIO icon
317
NIO
NIO
$11.9B
$1.02M 0.01%
200,000
-1,128,950
-85% -$8M
ORTX
318
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.02M 0.01%
5,699
-5,426
-49% -$816K
FHI icon
319
Federated Hermes
FHI
$4.72B
$981K 0.01%
+33,483
New +$930K
ARCE
320
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$978K 0.01%
30,282
-199,306
-87% -$5.07M
CYPH
321
CALL
Cypherpunk Technologies Inc
CYPH
$73.3M
$962K 0.01%
+51,429
New +$1.05M
TCDA
322
DELISTED
Tricida, Inc. Common Stock
TCDA
$961K 0.01%
24,876
-124
-0.5% -$2.89K
GNCA
323
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
$885K 0.01%
187,500
– –
CBMG
324
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$865K 0.01%
+50,000
New +$908K
TREX icon
325
Trex
TREX
$5.01B
$846K 0.01%
+27,506
New +$961K
11 12
13
14 15

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q1 2019 Portfolio in Review

As of Q1 2019, Alyeska Investment Group held 505 positions worth $7.57B, up 10% from $6.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Alyeska Investment Group withdrew a net $177B in Q1 2019, closing 138 positions and reducing 97 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $96.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in Intel worth $143M.

  • Alyeska Investment Group's largest Q1 2019 buy was Intel: 2,672,174 shares worth $143M.
  • Alyeska Investment Group added most to Activision Blizzard in Q1 2019, an estimated $132M increase.
  • Alyeska Investment Group's biggest Q1 2019 reduction was Flex, cutting an estimated $77.4M.
  • Alyeska Investment Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $96.2M.
  • Alyeska Investment Group's ten largest holdings make up 17% of its $7.57B portfolio in Q1 2019.
  • Alyeska Investment Group opened 149 new positions and closed 138 in Q1 2019.
  • Alyeska Investment Group's portfolio value rose 10% quarter-over-quarter to $7.57B.

Based on Alyeska Investment Group's 13F filing for Q1 2019, filed 15 May 2019.